Unknown

Dataset Information

0

Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.


ABSTRACT: In the human prion disease Creutzfeldt-Jakob disease (CJD), different CJD neuropathological subtypes are defined by the presence in normal prion protein (PrPC) of a methionine or valine at residue 129, by the molecular mass of the infectious prion protein PrPSc, by the pattern of PrPSc deposition, and by the distribution of spongiform change in the brain. Heterozygous cases of CJD potentially add another layer of complexity to defining CJD subtypes since PrPSc can have either a methionine (PrPSc-M129) or valine (PrPSc-V129) at residue 129. We have recently demonstrated that the relative amount of PrPSc-M129 versus PrPSc-V129, i.e. the PrPSc allotype ratio, varies between heterozygous CJD cases. In order to determine if differences in PrPSc allotype correlated with different disease phenotypes, we have inoculated 10 cases of heterozygous CJD (7 sporadic and 3 iatrogenic) into two transgenic mouse lines overexpressing PrPC with a methionine at codon 129. In one case, brain-region specific differences in PrPSc allotype appeared to correlate with differences in prion disease transmission and phenotype. In the other 9 cases inoculated, the presence of PrPSc-V129 was associated with plaque formation but differences in PrPSc allotype did not consistently correlate with disease incubation time or neuropathology. Thus, while the PrPSc allotype ratio may contribute to diverse prion phenotypes within a single brain, it does not appear to be a primary determinative factor of disease phenotype.

SUBMITTER: Ward A 

PROVIDER: S-EPMC7285538 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4740439 | BioStudies
1000-01-01 | S-EPMC2786774 | BioStudies
1000-01-01 | S-EPMC5701371 | BioStudies
2010-01-01 | S-EPMC2895666 | BioStudies
2006-01-01 | S-EPMC1316067 | BioStudies
2014-01-01 | S-EPMC4030982 | BioStudies
2020-01-01 | S-EPMC6954626 | BioStudies
2020-01-01 | S-EPMC7518762 | BioStudies
2008-01-01 | S-EPMC2706533 | BioStudies
1000-01-01 | S-EPMC3904628 | BioStudies